Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.

You will be able to view the event at https://videocast.nih.gov on the day of the event.

 

Demystifying Medicine 2019 - Inheritable Cancer

   
Air date: Tuesday, March 19, 2019, 4:00:00 PM
Time displayed is Eastern Time, Washington DC Local
iCalendar: Add event to iCalendar Add an upcoming event to your calendar.
Description: Demystifying Medicine Lecture Series

Cancer development often is a result of environmental factors, such as exposure to tobacco products and industrial toxins. Other times, however, cancer is written in the cards, nearly unavoidable, arising almost solely from genetic factors. These are so-called "inheritable cancers," and common types include cancers of the kidney, colon, and breast. Of course, what is inherited is a gene defect from a parent, not the cancer itself. Upwards of 10 percent of cancers may be the result of such inheritable mutations.

For this next lecture in the Demystifying Medicine series, now fortified with CME, we bring you two speakers who are investigating inheritable cancers from a clinical and epidemiological perspective. Marston Linehan, chief of the NCI CCR Urologic Oncology Branch, pioneered the study of the genetic basis of kidney cancer. His team identified the genes for the common forms of kidney cancer and described the pathways of these kidney cancer genes. His recent studies targeting the metabolic basis of kidney cancer have resulted in the regression of metastatic cancer in patients with type 1 and type 2 papillary kidney cancer.

Co-presenter Sharon Savage, DCEG Clinical Director and chief of the Clinical Genetics Branch, has studied the genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and autosomal-dominant cancer predisposition syndromes, such as Li-Fraumeni syndrome. She and her team are characterizing the clinical consequences of these disorders and are developing cancer screening programs.

For more information go to https://demystifyingmedicine.od.nih.gov
Author: Marston Linehan, MD, NCI, NIH and Sharon Savage, MD, NCI, NIH
Runtime: 2 hours